12:00 AM
 | 
Apr 15, 2013
 |  BC Week In Review  |  Company News  |  Deals

Epizyme, GlaxoSmithKline deal

Epizyme received a second $4 million milestone payment from GlaxoSmithKline under a January 2011 deal in which the companies partnered to discover, develop and commercialize small molecule therapeutics targeting...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >